Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs / May 25, 2017

Nanobodies: These Are Not Your Mother’s mAbs

View Post

Antisense, Biotech Basics, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Orphan Disease, Orphan Drugs, Ribonucleic Acid (RNA), The WEEKLY / April 27, 2017

RNA Therapeutics March Onward

View Post

Antisense, Biologics, Clinical Trials, Drug Development, Drug Targets, FDA, Genomics, Mechanism of Action, Orphan Disease, Orphan Drugs, Ribonucleic Acid (RNA), The WEEKLY / February 9, 2017

New Hope For Spinal Muscular Atrophy

View Post

Antisense, Biologics, Clinical Trials, Drug Development, Drug Targets, FDA, Genomics, Mechanism of Action, Orphan Disease, Orphan Drugs, Ribonucleic Acid (RNA), The WEEKLY / October 27, 2016

The Race To Beat SMA

View Post

Antisense, Biologics, Clinical Trials, Cocktail Fodder, Deoxyribonucleic Acid (DNA), Drug Approvals, Drug Development, Drug Targets, FDA, Genetics, Mechanism of Action, Orphan Disease, Orphan Drugs, Ribonucleic Acid (RNA), The WEEKLY / September 22, 2016

DMD Makes The Cut

View Post

Clinical Trials, Drug Approvals, Drug Development, Drug Targets, Easily Confused, Genetics, Mechanism of Action, Orphan Disease, Orphan Drugs, The WEEKLY / July 27, 2016

The Next Generation Fight Against CF

View Post

Biologics, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Genetics, Mechanism of Action, Orphan Disease, Orphan Drugs, The WEEKLY / July 14, 2016

A Drop Of Gene Therapy

View Post

Biologics, Clinical Trials, Cocktail Fodder, Drug Development, Drug Targets, Mechanism of Action, Orphan Disease, Orphan Drugs, Small Molecule Drugs / April 21, 2016

An Inborn Error Of Metabolism

View Post

Biotech Basics, Drug Development, Drug Targets, Genetics, Genomics, Mechanism of Action, Orphan Disease, Orphan Drugs, Term of the Week, The WEEKLY / March 24, 2016

On The Hunt

View Post

Biologics, Cardiovascular Disease, Drug Approvals, FDA, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY / January 7, 2016

Orphan Drugs Lead 2015 Approvals

View Post

Antisense, Clinical Trials, Drug Development, Drug Targets, FDA, Genetics, Orphan Disease, Orphan Drugs, Ribonucleic Acid (RNA), Small Molecule Drugs / September 10, 2015

Deciphering DMD

View Post

Cancer, Clinical Trials, Cocktail Fodder, Diagnostics, Drug Development, Genomics, HIV, Orphan Disease, Orphan Drugs, The WEEKLY / July 23, 2015

A Drop Of Biotech

View Post

Biologics, Clinical Trials, Drug Approvals, Drug Development, Drug Targets, FDA, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY / July 9, 2015

Targeting The Cause Of Cystic Fibrosis

View Post

Cancer, Clinical Trials, Drug Approvals, Drug Development, Drug Targets, Easily Confused, FDA, Genetics, Genomics, Mechanism of Action, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY / February 5, 2015

The State Of Cystic Fibrosis And Precision Medicine

View Post

Biologics, Biotech Basics, Business of Biotech, Cancer, Cardiovascular Disease, Clinical Trials, Diabetes, Diagnostics, Drug Approvals, Drug Development, Drug Targets, Ebola, FDA, Genetics, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs, Small Molecule Drugs, The WEEKLY / November 25, 2014

12 Biotech Concepts Everyone Should Know

View Post

Biologics, Biotech Basics, Cancer, Drug Targets, FDA, Mechanism of Action, Monoclonal Antibodies, Orphan Drugs, The WEEKLY / October 30, 2014

Biotech’s Battlefront: Monoclonal Antibodies

View Post